ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

January 17, 2003

Osteoporosis Treatments Associated With Decreased Risk Of Breast Cancer

March 26, 2010

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992